...
首页> 外文期刊>Saudi Pharmaceutical Journal >Novel oral dosage regimen based on self-nanoemulsifying drug delivery systems for codelivery of phytochemicals – Curcumin and thymoquinone
【24h】

Novel oral dosage regimen based on self-nanoemulsifying drug delivery systems for codelivery of phytochemicals – Curcumin and thymoquinone

机译:基于自纳中乳化药物递送系统的新型口腔剂量方案,用于植物化学症 - 姜黄素和胸腺量

获取原文
           

摘要

Background Curcumin and Thymoquinone are very well-known phytochemicals for their potent anti-inflammatory and anticancer properties. The major challenges for curcumin is its poor aqueous solubility and erratic oral bioavailability. Objective To develop a novel liquid self-nanoemulsifying drug delivery system (SNEDDS) containing curcumin and thymoquinone and further converted into a solid dosage form using adsorbents Syloid? and Neusilin? as the solid carrier. Methods The characterization of the liquid and solid SNEDDS was performed by particle size & zeta potential analysis, scanning electron microscopy, differential scanning calorimetry, fourier transform infrared spectroscopy and X-ray powder diffraction. The drug loading, and in vitro release studies were carried out to investigate the efficiency of curcumin release from SNEDDS. Results The liquid SNEDDS containing black seed oil showed excellent self-emulsification performance with transparent appearance. The results of characterization studies showed that solidification using 50% (w/w) Syloid? and Neusilin? in the liquid formulation yield free flowing powder with no agglomeration but Neusilin? produced smooth granules than Syloid? and kept the drugs stable in amorphous state. In vitro dissolution studies indicated that liquid SNEDDS formulations of F4 and its solid SNEDDS using Neusilin? provided high dissolution efficiency and reproducibility for curcumin and thymoquinone. However, Neusilin? showed higher rate of dissolution (more than 65%, p ?? 0.05 ) compared to Syloid? for curcumin. Conclusions Curcumin loaded-SNEDDS formulation containing thymoquinone in liquid & solid dosage forms were successfully developed with an increased drug loading and dissolution rate, which could be the potential combined delivery system for various anti-inflammatory and anti-cancer treatments.
机译:背景姜黄素和胸腺醌是非常熟知的植物化学症,适用于它们有效的抗炎和抗癌性能。姜黄素的主要挑战是其差的水溶性和不稳定的口腔生物利用度。目的开发一种含有姜黄素和胸腺酮的新型液体自纳乳化药物递送系统(SNEDDS),并使用吸附剂Syloid进一步转化为固体剂型?和neusilin?作为固体载体。方法采用粒径和Zeta电位分析,扫描电子显微镜,差分扫描量热法,傅里叶变换红外光谱和X射线粉衍射进行液体和固体鼻涕的表征。进行药物载荷和体外释放研究以研究姜黄素释放的姜黄素释放。结果含有黑色种子油的液体鼻涕显示出具有透明外观的优异的自乳化性能。表征研究结果表明,使用50%(w / w)syloid的凝固症状?和neusilin?在液体配方中,不含凝聚但Neusilin的自由流动粉末?生产的颗粒光滑而不是syloid?并使药物保持在非晶态状态。体外溶解研究表明,使用Neusilin的F4和其固体鼻涕的液体SnEdds配方?为姜黄素和胸腺量提供高溶出效率和再现性。然而,neusilin?与Syloid相比,显示出较高的溶解(超过65%,p?<-0.05)?对于姜黄素。结论成功开发了含有液体和固体剂型中含有苯醌的姜黄油加入的SnEdds制剂,增加药物负载和溶出速率,这可能是各种抗炎和抗癌治疗的潜在联合递送系统。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号